Author: Pamela Schumacher ASA Monitor June 2024, Vol. 88, The FIVA Flow attaches to any standard gravity-fed I.V. set to monitor fluid flow. It has been used since January 2023. The scene is typical – a dim OR filled with distracting noises, beeps, alarms, conversations, and the whine of surgical instruments. The anesthesiologist is busy […]
Read MoreWHO announces new AI resource The World Health Organization (WHO) has unveiled the Smart AI Resource Assistant for Health, or S.A.R.A.H., a digital health promoter prototype that uses generative artificial intelligence (AI) with enhanced empathetic response capabilities. S.A.R.A.H. operates 24/7 in eight languages across various devices, offering guidance on diverse health topics like healthy habits […]
Read MoreNonopioid postsurgical pain treatment option approved Cumberland Pharmaceuticals Inc. has announced U.S. Food and Drug Administration (FDA) approval of Caldolor® (intravenous ibuprofen, or IVIB) as a standard treatment for pain and fever across various patient demographics. Caldolor offers multimodal pain management, with clinical studies demonstrating IVIB’s significant efficacy in reducing temperature compared to placebo or acetaminophen, […]
Read MoreASA Monitor June 2024, Vol. 88, 6. Which of the following is MOST likely to be associated with an increased risk for postoperative urinary retention (POUR)? (A) Decreased intraoperative fluids (B) Male sex (C) Gynecologic surgery POUR is a common postsurgical complication. Depending on multiple interacting factors, the incidence ranges from 5%-70% (Table). Interdependence between risk […]
Read MoreInjectable approved to reduce liver fat content A National Institutes of Health (NIH)-funded study revealed that a weekly injection of semaglutide is safe and reduces liver fat by 31% in individuals with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD, previously known as nonalcoholic fatty liver disease, is a common chronic liver disease associated […]
Read More